Jonathan Poole, Chief Financial Officer at GENOCEA BIOSCIENCES, INC. (GNCA), bought 4,000 shares at $3.88 ($16K) on 2016-05-09, disclosed to the SEC on 2016-05-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Several strong factors at once. The rarest rating we give.
| Filing → |
| GNCA | BUY | 2016-11-09 | $23K | — | Filing → |